GLOBALLY RECOGNIZED EXPERTISE IN THE MANUFACTURING OF INJECTABLE PRODUCTS
Our Pau site is dedicated to the manufacture of injectable products with a high level of added value. It specializes in aseptic filling under isolators of cytotoxic and biotechnological anti-cancer products, the filling of bottles with liquids and lyophilisates, and pre-filled syringes. Its high-quality expertise is recognized throughout the world.
The site is certified by healthcare agencies in various regions: ANSM (France), EMA (Europe), FDA (United States) and PMDA (Japan).
AFNOR Certification certifies that the management system implemented by Pierre Fabre Médicament Production for the activities production and conditioning of pharmaceutical products has been assessed and found to meet the requirements of ISO 14001 : 2004.
Production unit of Pau in video
The site was designed and built in 1991 to manufacture Navelbine, Pierre Fabre Laboratories’ new anti-cancer drug. Since then, the Pau site has developed a unique expertise in the manufacturing of highly-toxic anti-cancer drugs under cutting-edge isolator technology. In 2005, Pierre Fabre built a second site dedicated to the processing of lyophilisates and liquids for anti-cancer products.
EXPERTISE AVAILABLE TO THIRD PARTIES
For 20 years, the Pau site has worked for third-party laboratories in producing clinical and industrial batches and offering a tailored service to clients, for the manufacture of active substances for finished products. A team of experts is available to clients to evaluate the technological transfer of products and to offer a procedure that guarantees the production quality and capacity.